We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
DPYD*2A/*5A/*9A and UGT1A1*6/*28 polymorphisms in Chinese colorectal cancer patients.
- Authors
Guo-Yin Li; Jian-Feng Duan; Wan-Jun Li; Tao Liu; Li, Guo-Yin; Duan, Jian-Feng; Li, Wan-Jun; Liu, Tao
- Abstract
<bold>Aim Of Study: </bold>Fluorouracil drugs and irinotecan are commonly used in the treatment of colorectal cancer (CRC), but some patients have severe toxic side effects in the conventional dose. DPYD*2A/*5A/*9A and UGT1A1 * 6/*28 polymorphisms are related to the toxicity of fluorouracil drugs and irinotecan, respectively. Herein, we investigated the frequencies of DPYD*2A/*5A/*9A and UGT1A1 * 6/*28 genotypes in Chinese CRC patients.<bold>Materials and Methods: </bold>For this study, 117 CRC patients' tumor tissues were examined through sequencing technology of the first generation to explore the distribution of DPYD*2A/*5A/*9A and UGT1A1 * 6/*28 genotypes.<bold>Results: </bold>DPYD*2A G/G genotype accounted for 100%. DPYD*5A A/A, A/G, and G/G genotypes accounted for 48.2, 37.5, and 14.3%, respectively. DPYD*9A T/T and T/C genotypes accounted for 85.7 and 14.3%, respectively. UGT1A1 * 6 G/G, G/A, and A/A genotypes accounted for 74.6, 21.8, and 3.6%, respectively. UGT1A1 * 28 TA6/TA6, TA6/TA7, and TA7/TA7 genotypes accounted for 71.8, 27.3, and 0.9%, respectively. The genotypes of DPYD*2A/*5A/*9A and UGT1A1 * 6/*28 were not associated with patient's sex, age, and primary tumor sites. Our findings showed that: (i) almost 57.1% of Chinese CRC patients had at least one variant of DPYD*5A and DPYD*9A; (ii) nearly 37.3% of Chinese CRC patients had at least one variant of UGT1A1 * 6 and UGT1A1 * 28.<bold>Conclusion: </bold>It suggests that it is necessary for Chinese CRC patients to detect the genotypes of DPYD*5A/*9A and UGT1A1 * 6/*28 before treating with fluorouracil drugs and irinotecan.
- Subjects
COLON cancer treatment; GENETIC polymorphisms; FLUOROURACIL; IRINOTECAN; DRUG side effects; ALLELES; COLON tumors; OXIDOREDUCTASES; RECTUM tumors; TRANSFERASES; CASE-control method; GENOTYPES
- Publication
Journal of Cancer Research & Therapeutics, 2016, Vol 12, Issue 2, p782
- ISSN
0973-1482
- Publication type
journal article
- DOI
10.4103/0973-1482.148685